220 related articles for article (PubMed ID: 32020232)
1. High PD‑L1 expression drives glycolysis via an Akt/mTOR/HIF‑1α axis in acute myeloid leukemia.
Ma P; Xing M; Han L; Gan S; Ma J; Wu F; Huang Y; Chen Y; Tian W; An C; Sun H; Sun L
Oncol Rep; 2020 Mar; 43(3):999-1009. PubMed ID: 32020232
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway.
Zhang Y; Liu Y; Xu X
J Cell Biochem; 2018 Jul; 119(7):6296-6308. PubMed ID: 29663500
[TBL] [Abstract][Full Text] [Related]
3. mTOR up-regulation of PFKFB3 is essential for acute myeloid leukemia cell survival.
Feng Y; Wu L
Biochem Biophys Res Commun; 2017 Feb; 483(2):897-903. PubMed ID: 28082200
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA 34b inhibits cell proliferation in pediatric acute myeloid leukemia via regulating LDHA.
Qi HX; Cao Q; Zhou GP; Sun XZ; Zhou WD; Hong Z; Hu J; Juan CX; Li S; Kuai WX
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5351-5359. PubMed ID: 31298387
[TBL] [Abstract][Full Text] [Related]
5. PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a.
Huang X; Xie X; Wang H; Xiao X; Yang L; Tian Z; Guo X; Zhang L; Tang H; Xie X
J Exp Clin Cancer Res; 2017 Sep; 36(1):129. PubMed ID: 28915924
[TBL] [Abstract][Full Text] [Related]
6. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A
Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991
[TBL] [Abstract][Full Text] [Related]
7. Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer.
Cai X; Ding H; Liu Y; Pan G; Li Q; Yang Z; Liu W
Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):119-127. PubMed ID: 28069585
[TBL] [Abstract][Full Text] [Related]
8. PTEN/AKT signaling mediates chemoresistance in refractory acute myeloid leukemia through enhanced glycolysis.
Ryu MJ; Han J; Kim SJ; Lee MJ; Ju X; Lee YL; Son JH; Cui J; Jang Y; Chung W; Song IC; Kweon GR; Heo JY
Oncol Rep; 2019 Nov; 42(5):2149-2158. PubMed ID: 31545464
[TBL] [Abstract][Full Text] [Related]
9. MACC1 regulates PDL1 expression and tumor immunity through the c-Met/AKT/mTOR pathway in gastric cancer cells.
Tong G; Cheng B; Li J; Wu X; Nong Q; He L; Li X; Li L; Wang S
Cancer Med; 2019 Nov; 8(16):7044-7054. PubMed ID: 31557409
[TBL] [Abstract][Full Text] [Related]
10. PARP14 promotes the growth and glycolysis of acute myeloid leukemia cells by regulating HIF-1α expression.
Zhu Y; Liu Z; Wan Y; Zou L; Liu L; Ding S; Lu C; Qiu F
Clin Immunol; 2022 Sep; 242():109094. PubMed ID: 35944879
[TBL] [Abstract][Full Text] [Related]
11. Glucose induced-AKT/mTOR activation accelerates glycolysis and promotes cell survival in acute myeloid leukemia.
Chen S; Tao Y; Wang Q; Ren J; Jing Y; Huang J; Zhang L; Li R
Leuk Res; 2023 May; 128():107059. PubMed ID: 36989577
[TBL] [Abstract][Full Text] [Related]
12. TRAF7 inhibits glycolysis to potentiate growth inhibition and apoptosis of myeloid leukemia cells via regulating the KLF2-PFKFB3 axis.
Zou L; Fang Y; He W
Mol Cell Probes; 2023 Jun; 69():101911. PubMed ID: 37003349
[TBL] [Abstract][Full Text] [Related]
13. PD-1/PD-L1 Interaction Regulates BCL2, KI67, BAX, and CASP3, Altering Proliferation, Survival, and Apoptosis in Acute Myeloid Leukemia.
Soltani M; Vosoughi M; Ganjalikhani-Hakemi M; Shapoorian H; Beshkar P; Eskandari N; Ghezelbash B
Iran J Allergy Asthma Immunol; 2023 Oct; 22(5):495-503. PubMed ID: 38085150
[TBL] [Abstract][Full Text] [Related]
14. Steroid receptor coactivator-3 regulates glucose metabolism in bladder cancer cells through coactivation of hypoxia inducible factor 1α.
Zhao W; Chang C; Cui Y; Zhao X; Yang J; Shen L; Zhou J; Hou Z; Zhang Z; Ye C; Hasenmayer D; Perkins R; Huang X; Yao X; Yu L; Huang R; Zhang D; Guo H; Yan J
J Biol Chem; 2014 Apr; 289(16):11219-11229. PubMed ID: 24584933
[TBL] [Abstract][Full Text] [Related]
15. Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia.
Gao Y; Gao J; Li M; Zheng Y; Wang Y; Zhang H; Wang W; Chu Y; Wang X; Xu M; Cheng T; Ju Z; Yuan W
J Hematol Oncol; 2016 Apr; 9():36. PubMed ID: 27071307
[TBL] [Abstract][Full Text] [Related]
16. SNS-032 inhibits mTORC1/mTORC2 activity in acute myeloid leukemia cells and has synergistic activity with perifosine against Akt.
Meng H; Jin Y; Liu H; You L; Yang C; Yang X; Qian W
J Hematol Oncol; 2013 Feb; 6():18. PubMed ID: 23415012
[TBL] [Abstract][Full Text] [Related]
17. Berberine decelerates glucose metabolism via suppression of mTOR‑dependent HIF‑1α protein synthesis in colon cancer cells.
Mao L; Chen Q; Gong K; Xu X; Xie Y; Zhang W; Cao H; Hu T; Hong X; Zhan YY
Oncol Rep; 2018 May; 39(5):2436-2442. PubMed ID: 29565467
[TBL] [Abstract][Full Text] [Related]
18. AGR2-induced glucose metabolism facilitated the progression of endometrial carcinoma via enhancing the MUC1/HIF-1α pathway.
Gong W; Ekmu B; Wang X; Lu Y; Wan L
Hum Cell; 2020 Jul; 33(3):790-800. PubMed ID: 32304027
[TBL] [Abstract][Full Text] [Related]
19. M2‑TAM subsets altered by lactic acid promote T‑cell apoptosis through the PD‑L1/PD‑1 pathway.
Shan T; Chen S; Chen X; Wu T; Yang Y; Li S; Ma J; Zhao J; Lin W; Li W; Cui X; Kang Y
Oncol Rep; 2020 Nov; 44(5):1885-1894. PubMed ID: 33000216
[TBL] [Abstract][Full Text] [Related]
20. LRRC1 knockdown downregulates MACF1 to inhibit the malignant progression of acute myeloid leukemia by inactivating β-catenin/c-Myc signaling.
Wang Y; Tong H; Wang J; Hu L; Huang Z
J Mol Histol; 2024 Feb; 55(1):37-50. PubMed ID: 38165568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
